United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 7, 2026 · Filed Apr 8, 2026

On Apr 7, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$564.01 for US$5.36M under a trading plan, leaving 40,513 shares. Filed Apr 8, 2026 (Form 4).

Sold
9,500 shares
Price
US$564.01 average (US$556.89 to US$569.62)
Value
US$5.36M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 7, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 7, 2026Common StockSale39US$556.8949,974Direct
Apr 7, 2026Common StockSale276US$558.3249,698Direct
Apr 7, 2026Common StockSale365US$559.2149,333Direct
Apr 7, 2026Common StockSale520US$560.3648,813Direct
Apr 7, 2026Common StockSale360US$561.6748,453Direct
Apr 7, 2026Common StockSale1,069US$562.3547,384Direct
Apr 7, 2026Common StockSale1,449US$563.4745,935Direct
Apr 7, 2026Common StockSale2,512US$564.6743,423Direct
Apr 7, 2026Common StockSale1,737US$565.6641,686Direct
Apr 7, 2026Common StockSale431US$566.6341,255Direct
Apr 7, 2026Common StockSale322US$567.6440,933Direct
Apr 7, 2026Common StockSale296US$568.7440,637Direct
Apr 7, 2026Common StockSale124US$569.6240,513Direct

Source

View original at SEC

Related